Until more safeguards are in place for artificially intelligent companions like Character AI or Replika to eliminate ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Asthma is one of the most common chronic respiratory conditions, with around 300 million people living with the condition ...

Opinion: Sullivan & Cromwell attorneys Frank Aquila and Catherine Yuh say firms that don't take advantage of AI to identify M ...

Researchers from Denmark and the United States have developed a powerful new artificial intelligence system that can predict events in people’s lives—including estimating when someone might die. This ...

If generative AI companies aren’t an asset bubble, then they've gone to a lot of trouble to look like one. The post The latest AI-powered martech news and releases appeared first on MarTech.

Journalists have uncovered a handful of preprint academic studies with hidden prompts instructing A.I. reviewers to give ...

LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, announced its consolidated results today for the first quarter ended June 30, 2025, as approved by ...

As the EU launches its €1 billion Innovation Fund to decarbonize industrial heat, Brenmiller enters as a proven, ...

“There is a widening gap between what AI can do and what it is actually doing to serve real businesses,” says Andrew Maren, ...

With its IPO just around the corner, will Lenskart’s smart glasses move prove to be the next growth arc or a risky bet?

EFA offers developed market exposure but suffers from weak growth drivers and redundancy versus U.S. stocks, limiting appeal.